Status:
COMPLETED
Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This Phase IV study is intended to compare intragastric acid suppression of oral esomeprazole (NEXIUM ® Delayed-Release Capsules) with that of oral pantoprazole (PROTONIX ® Delayed Release Tablets ), ...
Eligibility Criteria
Inclusion
- Provision of informed consent.
- Males and females aged 18 to 70 years, inclusive.
- Male or non-pregnant, nonlactating female healthy volunteer subjects. Females must be post-menopausal, surgically sterilized, or using a medically acceptable form of birth control, as determined by the investigator. Women of childbearing potential must agree to continue using an acceptable form of birth control throughout the conduct of the study.
Exclusion
- Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the investigational site)
- Previous enrollment or randomization of treatment in the present study.
- Received an experimental drug or used an experimental device within 28 days preceeding the screening visit.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00206050
Start Date
September 1 2004
End Date
December 1 2004
Last Update
January 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Oklahoma City, Oklahoma, United States